NEW YORK (Reuters Health) – Vaginal misoprostol applied prior to intrauterine device (IUD) insertion does not make the procedure go any easier or lessen the patient’s pain, a…
NEW YORK (Reuters Health) – Women with latent celiac disease — positive celiac antibodies but a normal small bowel biopsy — may be at increased risk of reproductive…
NEW YORK (Reuters Health) – Intrapartum translabial ultrasound (ITU) appears to be an effective way to monitor birth progress in term fetuses in cephalic presentation, researchers reported online…
NEW YORK (Reuters Health) – Office-based endometrial ablation for menorrhagia is equally effective with thermal balloon ablation or bipolar radiofrequency, U.K. researchers say. Six months after randomization and…
NEW YORK (Reuters Health) – Menses and ovulation are more likely to resume spontaneously after chemotherapy if women also receive a gonadotropin-releasing hormone (GnRH) analog – but pregnancy…
NEW YORK (Reuters Health) – Noninvasive uterine electromyography (EMG) identifies true preterm labor more accurately than clinical methods now in use, new research shows. “It can therefore identify…
NEW YORK (Reuters Health) – For women of normal weight or moderate overweight who develop gestational diabetes late in pregnancy, treatment with metformin may be a suitable alternative…
NEW YORK (Reuters Health) – While elevated levels of anticardiolipin antibodies are associated with preeclampsia, measuring levels of anticardiolipin antibodies cannot be used to predict risk of preeclampsia…
NEW YORK (Reuters Health) – Over time, cervical intraepithelial neoplasia (CIN) grade 2 eventually resolves spontaneously in about two-thirds of adolescent and young adult women, according to findings…
NEW YORK (Reuters Health) – Ultrasound-guided high-intensity focused ultrasound (HIFU) ablation and the levonorgestrel intrauterine system (LNG-IUS) offer less invasive options for treating women with symptomatic adenomyosis, according…